Arctic Bioscience AS (OSL:ABS)

Norway · Delayed Price · Currency is NOK

3.160

-0.020 (-0.63%)

Jun 4, 2026, 9:59 AM CET

Revenue by Segment

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
B2C	4.85M	4.95M	4.28M	3.49M			-
B2C Growth	-2.12%	15.89%	22.34%	-			-
B2B	35.25M	38.53M	29.47M	30.78M			-
B2B Growth	-8.52%	30.72%	-4.23%	-			-
Pharmaceuticals	-	-	-	-			30.04M
Pharmaceuticals Growth	-	-	-	-			20.89%
Total	40.10M	43.48M	33.75M	34.27M			30.04M
Total Growth	-7.79%	28.84%	-1.52%	-			20.89%

Revenue by Geography

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Norway	7.29M	6.89M	6.04M	4.96M			-
Norway Growth	5.85%	14.09%	21.73%	-			-
Americas	13.32M	5.47M	5.52M	7.62M			-
Americas Growth	143.51%	-0.98%	-27.50%	-			-
Europe	11.46M	18.55M	12.42M	8.50M			-
Europe Growth	-38.24%	49.38%	46.07%	-			-
APAC	8.02M	12.57M	9.77M	13.19M			-
APAC Growth	-36.17%	28.71%	-25.95%	-			-
Total	40.10M	43.48M	33.75M	34.27M			-
Total Growth	-7.79%	28.84%	-1.52%	-			-

Source: S&P Global Market Intelligence.